High-Throughput Functional Evaluation of <i>MAP2K1</i> Variants in Cancer
Sho Mizuno(Tokyo Metropolitan Komagome Hospital), Shinji Kohsaka(National Cancer Research Institute), Hidenori Kage(The University of Tokyo), Yutaka Osuga(The University of Tokyo), Takafumi Koyama(Tokyo National Hospital), Hiroshi Ikeuchi(Juntendo University), Mitsuru Yanagaki(Jikei University School of Medicine), Dai Ogata(University of Miyazaki), Michihiro Tanikawa(The University of Tokyo), Toshihide Ueno, Kuniko Sunami(Tokyo National Hospital), Katsutoshi Oda(The University of Tokyo), Hiroyuki Mano(National Cancer Research Institute), Masachika Ikegami(The University of Tokyo)
Cited by 32
Related Papers
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
|Cancer Cell|2022|828
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
|Nature Immunology|2020|810
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338